MX345780B - Inhibidores triciclicos de girasa. - Google Patents

Inhibidores triciclicos de girasa.

Info

Publication number
MX345780B
MX345780B MX2013010511A MX2013010511A MX345780B MX 345780 B MX345780 B MX 345780B MX 2013010511 A MX2013010511 A MX 2013010511A MX 2013010511 A MX2013010511 A MX 2013010511A MX 345780 B MX345780 B MX 345780B
Authority
MX
Mexico
Prior art keywords
gyrase inhibitors
tricyclic gyrase
compounds
tricyclic
inhibitors
Prior art date
Application number
MX2013010511A
Other languages
English (en)
Other versions
MX2013010511A (es
Inventor
John Finn
Junhu Zhang
Michael Jung
Douglas Phillipson
Daniel Bensen
Suk Joong Lee
Zhiyong Chen
Thanh To Lam
Xiaoming Li
Michael Trzoss
Toan B Nguyen
Felice Lightstone
Leslie William Tari
Paul Aristoff
Sergio E Wong
Original Assignee
Trius Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trius Therapeutics Inc filed Critical Trius Therapeutics Inc
Publication of MX2013010511A publication Critical patent/MX2013010511A/es
Publication of MX345780B publication Critical patent/MX345780B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

Se divulgan compuestos con la estructura de la Fórmula I y sales, ésteres, y profármacos de los mismos, farmacéuticamente adecuados que son útiles como inhibidores tricíclicos de girasa eficaces contra las bacterias. También se contemplan composiciones, usos y métodos farmacéuticamente relacionados para obtener los compuestos.
MX2013010511A 2011-03-15 2012-03-14 Inhibidores triciclicos de girasa. MX345780B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161453011P 2011-03-15 2011-03-15
PCT/US2012/029104 WO2012125746A1 (en) 2011-03-15 2012-03-14 Tricyclic gyrase inhibitors

Publications (2)

Publication Number Publication Date
MX2013010511A MX2013010511A (es) 2014-03-27
MX345780B true MX345780B (es) 2017-02-15

Family

ID=45879060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010511A MX345780B (es) 2011-03-15 2012-03-14 Inhibidores triciclicos de girasa.

Country Status (15)

Country Link
US (2) US9732083B2 (es)
EP (1) EP2686320B1 (es)
JP (1) JP6140083B2 (es)
KR (2) KR20140059164A (es)
CN (1) CN103562208B (es)
AR (1) AR085806A1 (es)
AU (1) AU2012229997B2 (es)
BR (1) BR112013023266B8 (es)
CA (1) CA2829939C (es)
IL (1) IL228220A (es)
MX (1) MX345780B (es)
RU (1) RU2626979C2 (es)
TW (1) TWI527818B (es)
WO (1) WO2012125746A1 (es)
ZA (1) ZA201307583B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI527818B (zh) 2011-03-15 2016-04-01 特留斯治療學有限公司 三環旋轉酶抑制劑
SG11201404241SA (en) * 2012-01-27 2014-08-28 Univ Montreal Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
WO2014043272A1 (en) * 2012-09-12 2014-03-20 Trius Therapeutics Inc. Tricyclic gyrase inhibitors for use as antibacterial agents
CN103304488B (zh) * 2013-06-13 2015-12-09 暨明医药科技（苏州）有限公司 光学纯2-（1-羟基乙基）-5-羟基嘧啶的制备方法
AU2014318838B2 (en) * 2013-09-11 2018-06-07 Lawrence Livermore National Security, Llc Tricyclic gyrase inhibitors
AU2015212495A1 (en) 2014-02-03 2016-08-18 Spero Gyrase, Inc. Antibacterial combinations comprising polymyxin
WO2015150337A1 (en) * 2014-04-01 2015-10-08 Amakem Nv Lim kinase inhibitors
US20210070747A1 (en) 2017-03-24 2021-03-11 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
CN110475777B (zh) * 2017-03-30 2022-04-15 豪夫迈·罗氏有限公司 用于治疗和预防细菌感染的新吡啶并[2,3-b]吲哚化合物
CN108504647B (zh) * 2018-03-09 2021-11-05 中山大学 一种dna促旋酶的药物结合口袋及其应用
WO2019228940A1 (en) 2018-05-28 2019-12-05 F. Hoffmann-La Roche Ag Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infection
EP3856747B1 (en) * 2018-09-26 2023-07-19 F. Hoffmann-La Roche AG Substituted pyridoindoles for the treatment and prophylaxis of bacterial infection
JP7463369B2 (ja) 2018-11-27 2024-04-08 エフ． ホフマン－ラ ロシュ アーゲー 細菌性感染症の処置および予防のためのアリール化合物
WO2020109190A1 (en) 2018-11-27 2020-06-04 F. Hoffmann-La Roche Ag Tricyclic compounds for the treatment and prophylaxis of bacterial infection
WO2020127624A1 (en) 2018-12-20 2020-06-25 F. Hoffmann-La Roche Ag Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infection
CN114763357A (zh) * 2021-01-15 2022-07-19 中国科学院上海药物研究所 吲哚并嘧啶三环类化合物及其制备方法和用途

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN157280B (es) 1983-07-15 1986-02-22 Hoechst India
CA1336090C (en) 1988-08-31 1995-06-27 Isao Hayakawa Spiro-substituted cyclic amines of quinolone derivatives
DE4030059A1 (de) 1990-09-22 1992-03-26 Bayer Ag Verfahren zur herstellung von 5-hydroxy-3,4,5,6-tetrahydro-pyrimidin-derivaten
DE4032560A1 (de) 1990-10-13 1992-04-16 Bayer Ag 7-(2,7-diazabicyclo(3.3.0)octyl)-3-chinolon- und -naphtyridoncarbonsaeure-derivate
RU2103272C1 (ru) 1992-04-03 1998-01-27 Дзе Апджон Компани Бициклические гетероциклические амины и их фармацевтически приемлемые соли, бициклические гетероциклические амины и их фармацевтически приемлемые соли в качестве ингибитора реакционноспособного кислорода
US5279359A (en) 1992-06-26 1994-01-18 Erickson Donald C Rotary trisorption heat pump
US5350791A (en) 1992-07-02 1994-09-27 Henkel Corporation Hydrophilicizing treatment for metal objects
US5527910A (en) 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
RU2158127C2 (ru) * 1994-12-23 2000-10-27 Варнер-Ламберт Компани Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция
KR19980702716A (ko) 1995-03-02 1998-08-05 웰츠로렌스티 피리미도[4,5-비]인돌
TR199800012T1 (xx) * 1995-07-06 1998-04-21 Novartis Ag Piroloprimidinler ve preparasyon i�in tatbikler.
WO1998029397A1 (fr) 1996-12-27 1998-07-09 Yoshitomi Pharmaceutical Industries, Ltd. Composes pyrimidine a anneaux condenses et leur utilisation medicinale
CN1128798C (zh) 1997-01-08 2003-11-26 法玛西雅厄普约翰美国公司 具有药物活性的三环胺类
CZ297206B6 (cs) 1997-07-29 2006-10-11 Pharmacia & Upjohn Company Farmaceutická kompozice a samoemulgující formulace pro lipofilní slouceniny
US6147085A (en) 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
AU3220299A (en) 1998-04-02 1999-10-25 Neurogen Corporation Substituted 9h-pyridino(2,3-b)indole and 9h-pyrimidino(4,5-b)indole derivatives:selective neuropeptide y receptor ligands
EP1068207A1 (en) 1998-04-02 2001-01-17 Neurogen Corporation AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
JP2000038350A (ja) 1998-05-18 2000-02-08 Yoshitomi Pharmaceut Ind Ltd 糖尿病治療薬
US6284766B1 (en) 1999-04-30 2001-09-04 Neurogen Corporation 9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands
WO2001053273A1 (en) 2000-01-24 2001-07-26 Warner-Lambert Company 3-aminoquinazolin-2,4-dione antibacterial agents
FR2816509B1 (fr) 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene
MXPA04004019A (es) 2001-10-31 2004-07-08 Bayer Healthcare Ag Derivados de pirimido?4,5-b?indol.
US20030216479A1 (en) 2001-11-08 2003-11-20 Liren Huang Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof
WO2003057149A2 (en) 2001-12-28 2003-07-17 Bayer Corporation 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
TWI270549B (en) 2002-12-26 2007-01-11 Taisho Pharmaceutical Co Ltd Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
WO2004058764A1 (en) * 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
US20090099165A1 (en) 2003-10-14 2009-04-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20080051414A1 (en) 2003-10-14 2008-02-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
US20090143399A1 (en) * 2003-10-14 2009-06-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Protein Kinase Inhibitors
EP1678166B1 (en) * 2003-10-14 2009-07-29 The Arizona Board of Regents on Behalf of the University of Arizona Protein kinase inhibitors
JP2006036762A (ja) 2004-06-25 2006-02-09 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
JP2007161585A (ja) 2004-06-25 2007-06-28 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
WO2008007113A2 (en) 2006-07-14 2008-01-17 Astex Therapeutics Limited Pharmaceutical combinations
KR20080020602A (ko) 2005-04-28 2008-03-05 수퍼젠, 인크. 단백질 키나아제 저해제
ATE411300T1 (de) * 2005-08-05 2008-10-15 Hybrigenics Sa Neue cysteine protease hemmers und ihre therapeutische anwendungen
US20070049591A1 (en) 2005-08-25 2007-03-01 Kalypsys, Inc. Inhibitors of MAPK/Erk Kinase
JP2007169216A (ja) 2005-12-22 2007-07-05 Taisho Pharmaceut Co Ltd 環状アミノ基で置換されているピロロピリミジン及びピロロピリジン誘導体
US20080207632A1 (en) 2006-10-31 2008-08-28 Supergen, Inc. Protein kinase inhibitors
WO2009004329A1 (en) 2007-07-02 2009-01-08 Cancer Research Technology Limited 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors
US7982035B2 (en) 2007-08-27 2011-07-19 Duquesne University Of The Holy Spirit Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof
US7960400B2 (en) * 2007-08-27 2011-06-14 Duquesne University Of The Holy Ghost Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
WO2009091476A1 (en) 2008-01-14 2009-07-23 Irm Llc Compositions and methods for treating cancers
ATE546448T1 (de) * 2008-08-02 2012-03-15 Janssen Pharmaceutica Nv Urotensin-ii-rezeptorantagonisten
WO2011056739A1 (en) 2009-11-03 2011-05-12 Glaxosmithkline Llc Compounds and methods
TWI527818B (zh) 2011-03-15 2016-04-01 特留斯治療學有限公司 三環旋轉酶抑制劑
WO2014043272A1 (en) * 2012-09-12 2014-03-20 Trius Therapeutics Inc. Tricyclic gyrase inhibitors for use as antibacterial agents
AU2014318838B2 (en) * 2013-09-11 2018-06-07 Lawrence Livermore National Security, Llc Tricyclic gyrase inhibitors
WO2016067009A1 (en) * 2014-10-28 2016-05-06 Redx Pharma Plc Compounds with activity against bacteria and mycobacteria

Also Published As

Publication number Publication date
WO2012125746A9 (en) 2013-10-24
AR085806A1 (es) 2013-10-30
BR112013023266A8 (pt) 2018-06-12
AU2012229997A1 (en) 2013-09-19
AU2012229997B2 (en) 2016-04-14
CN103562208B (zh) 2016-08-31
US10858360B2 (en) 2020-12-08
CN103562208A (zh) 2014-02-05
US20120238751A1 (en) 2012-09-20
JP6140083B2 (ja) 2017-05-31
BR112013023266B1 (pt) 2020-12-29
IL228220A0 (en) 2013-11-25
JP2014508173A (ja) 2014-04-03
EP2686320A1 (en) 2014-01-22
RU2626979C2 (ru) 2017-08-02
MX2013010511A (es) 2014-03-27
NZ614983A (en) 2016-07-29
ZA201307583B (en) 2014-08-27
RU2013140798A (ru) 2015-04-20
US20170369498A1 (en) 2017-12-28
TWI527818B (zh) 2016-04-01
TW201245200A (en) 2012-11-16
CA2829939C (en) 2020-10-13
EP2686320B1 (en) 2016-05-18
KR102132574B1 (ko) 2020-07-09
CA2829939A1 (en) 2012-09-20
BR112013023266B8 (pt) 2021-04-06
IL228220A (en) 2017-04-30
WO2012125746A1 (en) 2012-09-20
BR112013023266A2 (es) 2017-09-12
KR20190104632A (ko) 2019-09-10
US9732083B2 (en) 2017-08-15
KR20140059164A (ko) 2014-05-15

Similar Documents

Publication Publication Date Title
MX2013010511A (es) Inhibidores triciclicos de girasa.
IN2014MN02598A (es)
MX2016006336A (es) Compuestos pirazolopirimidina.
UA107954C2 (en) Substituted pyrrolidin-2-carboxamide
PH12014502733A1 (en) Neprilysin inhibitors
EP4219465A3 (en) Prmt5 inhibitors and uses thereof
AU2012214029A8 (en) Rorgammat inhibitors
WO2014028600A3 (en) 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
IN2014MN02657A (es)
IN2014MN02652A (es)
EA201170434A1 (ru) Макроциклические ингибиторы сериновых протеаз гепатита с
MY172924A (en) Neprilysin inhibitors
MX2015012850A (es) Inhibidores de la arginina metiltransferasa y usos de los mismos.
PH12014501542B1 (en) Substituted pyrrolidine -2- carboxamides
IN2014CN04530A (es)
IN2015DN01119A (es)
AU2012213775A8 (en) 7-azaindole derivatives
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2012173682A3 (en) Compounds and methods for the treatment of isocitrate dehydrognase related diseases
MD4556B1 (ro) Compuşi inhibitori ai activităţii catehol O-metiltransferazei
MY186599A (en) Substituted pyridopyrazines as novel syk inhibitors
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
EA201492287A1 (ru) Дейтерированные производные руксолитиниба
WO2014031872A3 (en) Small molecule inhibitors for treating parasitic infections

Legal Events

Date Code Title Description
FG Grant or registration